RhumbLine Advisers’s Lunai Bioworks Inc. Common Stock RENB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-123,006
| Closed | -$66.8K | – | 4243 |
|
|
2025
Q1 | $66.8K | Buy |
123,006
+10,046
| +9% | +$5.45K | ﹤0.01% | 3502 |
|
|
2024
Q4 | $94.4K | Buy |
112,960
+62,204
| +123% | +$52K | ﹤0.01% | 3490 |
|
|
2024
Q3 | $24.5K | Buy |
50,756
+5,559
| +12% | +$2.68K | ﹤0.01% | 3796 |
|
|
2024
Q2 | $79.1K | Buy |
+45,197
| New | +$79.1K | ﹤0.01% | 3584 |
|
|
2023
Q3 | – | Sell |
-5,517
| Closed | -$3.13K | – | 4352 |
|
|
2023
Q2 | $3.13K | Sell |
5,517
-24,981
| -82% | -$14.2K | ﹤0.01% | 4158 |
|
|
2023
Q1 | $28K | Buy |
30,498
+1,208
| +4% | +$1.11K | ﹤0.01% | 2927 |
|
|
2022
Q4 | $30K | Buy |
29,290
+151
| +0.5% | +$155 | ﹤0.01% | 2975 |
|
|
2022
Q3 | $53K | Buy |
29,139
+438
| +2% | +$797 | ﹤0.01% | 3041 |
|
|
2022
Q2 | $55K | Buy |
+28,701
| New | +$55K | ﹤0.01% | 3058 |
|
|
2021
Q2 | – | Sell |
-15,032
| Closed | -$53K | – | 3088 |
|
|
2021
Q1 | $53K | Buy |
15,032
+100
| +0.7% | +$353 | ﹤0.01% | 2974 |
|
|
2020
Q4 | $44K | Buy |
14,932
+2,905
| +24% | +$8.56K | ﹤0.01% | 3025 |
|
|
2020
Q3 | $43K | Sell |
12,027
-1,979
| -14% | -$7.08K | ﹤0.01% | 2957 |
|
|
2020
Q2 | $59K | Buy |
+14,006
| New | +$59K | ﹤0.01% | 3021 |
|